Clinical Trial Update: Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

View source ↗

Summary

This clinical trial update reports the completion and posting of results for Pfizer's postmarketing surveillance of the Prevenar pneumococcal vaccine in Japan a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease
• Streptococcus Pneumoniae Infection

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Vaccine, Streptococcus Pneumoniae | Status: COMPLETED | Results posted: 2016-01-20